Modulation of Mucosal and Systemic Immunity by Hormonal Contraceptives
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 15 - 25 |
Updated: | 1/1/2014 |
Start Date: | December 2012 |
End Date: | January 2017 |
Contact: | Thomas L. Cherpes, MD |
Email: | cherpestl@upmc.edu |
Phone: | 412 692 9563 |
The investigators are conducting a research study to understand how cells responsible for
fighting infection (immune cells) are affected by hormonal contraceptive use. The
investigators hypothesize that progestin-containing hormonal contraceptives (i.e.,
Depo-Provera) inhibit host response to infection. To test this hypothesis, the
investigators will collect blood and genital tract samples from women before and after their
initiation of a hormonal contraceptive (either birth control pills, Depo-Provera, or
Mirena).
fighting infection (immune cells) are affected by hormonal contraceptive use. The
investigators hypothesize that progestin-containing hormonal contraceptives (i.e.,
Depo-Provera) inhibit host response to infection. To test this hypothesis, the
investigators will collect blood and genital tract samples from women before and after their
initiation of a hormonal contraceptive (either birth control pills, Depo-Provera, or
Mirena).
Inclusion Criteria:
1. 15-25 years of age (inclusive)
2. History of regular menstrual cycle
3. Not pregnant
4. No plan to become pregnant in the next 3 months
5. Interested in beginning use of OC, DMPA, or LNG-IUD
6. Able to read and provide written informed consent (and consent from a parent/guardian
if the participant is a minor)
Exclusion Criteria:
1. Anticipated move out of area that prevents return for a follow-up visit
2. Unavailability for follow-up visit
3. Less than 90 days post-partum or post-abortion
4. Sexually transmitted infection (STI) diagnosed less than 30 days prior to enrollment
5. Use of OC, contraceptive ring or patch, single rod implant, LNG-IUD, or
copper-containing IUD less than 3 months prior to enrollment
6. DMPA injection less than 6 months prior to enrollment
7. History of immunosuppressive condition of current use of immunosuppressive
medications
8. History of a cervical malignancy
9. Detection of cervical anatomic pathologic conditions that preclude cervical biopsy
procurement
10. Intolerance or contradiction to use of OC, DMPA, or LNG-IUD
We found this trial at
1
site
Click here to add this to my saved trials